Search for other papers by Feifei Cheng in
Google Scholar
PubMed
Search for other papers by Noel Yat Hey Ng in
Google Scholar
PubMed
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Search for other papers by Claudia Ha Ting Tam in
Google Scholar
PubMed
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Search for other papers by Yuying Zhang in
Google Scholar
PubMed
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Search for other papers by Cadmon King Poo Lim in
Google Scholar
PubMed
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Search for other papers by Guozhi Jiang in
Google Scholar
PubMed
Search for other papers by Alex Chi Wai Ng in
Google Scholar
PubMed
Search for other papers by Tiffany Tse Ling Yau in
Google Scholar
PubMed
Search for other papers by Lai Ping Cheung in
Google Scholar
PubMed
State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, Hong Kong
Department of Pharmacy and Pharmacology, LKS Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong
Search for other papers by Aimin Xu in
Google Scholar
PubMed
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Chinese University of Hong Kong-Shanghai Jiao Tong University Joint Research Centre in Diabetes Genomics and Precision Medicine, Hong Kong, Hong Kong
Search for other papers by Juliana C N Chan in
Google Scholar
PubMed
Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Chinese University of Hong Kong-Shanghai Jiao Tong University Joint Research Centre in Diabetes Genomics and Precision Medicine, Hong Kong, Hong Kong
Search for other papers by Ronald C W Ma in
Google Scholar
PubMed
) family, FGF19 and FGF21, have been shown to be associated with obesity and diabetes ( 10 , 11 , 12 ). Moreover, serum FGF21 can predict the development of T2DM in the normal population, as well as being associated with incident coronary heart disease
Department of Pediatrics, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
Search for other papers by Anru Wang in
Google Scholar
PubMed
Search for other papers by Xueqin Yan in
Google Scholar
PubMed
Search for other papers by Cai Zhang in
Google Scholar
PubMed
Search for other papers by Caiqi Du in
Google Scholar
PubMed
Search for other papers by Wenjun Long in
Google Scholar
PubMed
Search for other papers by Di Zhan in
Google Scholar
PubMed
Search for other papers by Xiaoping Luo in
Google Scholar
PubMed
. Recent clinical and animal studies have reported that FGF19 and FGF21 are associated with obesity and T2DM ( 2 , 3 ). FGF19 and FGF21 suppress triglyceride and glucose syntheses, meanwhile inducing glycogenesis and fatty acid oxidation in the liver
Search for other papers by Huixing Liu in
Google Scholar
PubMed
Search for other papers by Daoquan Peng in
Google Scholar
PubMed
A1; SRB1, scavenger receptor b1; FGF19/21, fibroblast growth factors 19/21; HMG-COA, 3-hydroxy-3-methyl glutaryl coenzyme A; ACC, acetyl-CoA carboxylase; FAS, fatty acid synthase; CPT1A, carnitine palmitoyltransferase Iα; WAT, white adipose tissue
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Service of Endocrinology, Laboratory of Intensive Care, Department of Microbiology and Molecular Medicine, Diabetes, Hypertension and Nutrition
Search for other papers by Geneviève Drifte in
Google Scholar
PubMed
Service of Endocrinology, Laboratory of Intensive Care, Department of Microbiology and Molecular Medicine, Diabetes, Hypertension and Nutrition
Search for other papers by Irène Dunn-Siegrist in
Google Scholar
PubMed
Service of Endocrinology, Laboratory of Intensive Care, Department of Microbiology and Molecular Medicine, Diabetes, Hypertension and Nutrition
Search for other papers by Jérôme Pugin in
Google Scholar
PubMed
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
Introduction Fibroblast growth factor 21 (FGF21) is a member of the FGF superfamily, consisting of FGF19, FGF21, and FGF23 (1, 2, 3, 4) . Because they lack the conventional FGF-heparin-binding domain, these FGFs can escape the body's vast
Search for other papers by Helle Keinicke in
Google Scholar
PubMed
Search for other papers by Gao Sun in
Google Scholar
PubMed
Search for other papers by Caroline M Junker Mentzel in
Google Scholar
PubMed
Search for other papers by Merete Fredholm in
Google Scholar
PubMed
Search for other papers by Linu Mary John in
Google Scholar
PubMed
Search for other papers by Birgitte Andersen in
Google Scholar
PubMed
Search for other papers by Kirsten Raun in
Google Scholar
PubMed
Search for other papers by Marina Kjaergaard in
Google Scholar
PubMed
://ir.akerotx.com/news-releases/news-release-details/all-akr-001-dose-groups-met-week-12-efficacy-endpoints-nash ) 72 Hansen AMK Vienberg SG Lykkegaard K Zhao X Tingqing G Han D Zhang X Thogersen H Sass-Orum K Tagmose T , Differential receptor selectivity of the FGF15/FGF19 orthologues
Key Laboratory of Sports Technique, Tactics and Physical Function of General Administration of Sport of China, Scientific Research Center, Guangzhou Sport University, Guangzhou, China
Search for other papers by Wenqi Yang in
Google Scholar
PubMed
Search for other papers by Ling Liu in
Google Scholar
PubMed
Key Laboratory of Sports Technique, Tactics and Physical Function of General Administration of Sport of China, Scientific Research Center, Guangzhou Sport University, Guangzhou, China
Search for other papers by Yuan Wei in
Google Scholar
PubMed
Key Laboratory of Sports Technique, Tactics and Physical Function of General Administration of Sport of China, Scientific Research Center, Guangzhou Sport University, Guangzhou, China
Search for other papers by Chunlu Fang in
Google Scholar
PubMed
Search for other papers by Fu Zhou in
Google Scholar
PubMed
Search for other papers by Jinbao Chen in
Google Scholar
PubMed
Search for other papers by Qinghua Han in
Google Scholar
PubMed
Search for other papers by Meifang Huang in
Google Scholar
PubMed
Search for other papers by Xuan Tan in
Google Scholar
PubMed
Search for other papers by Qiuyue Liu in
Google Scholar
PubMed
Search for other papers by Qiang Pan in
Google Scholar
PubMed
Search for other papers by Lu Zhang in
Google Scholar
PubMed
Search for other papers by Xiaojuan Lei in
Google Scholar
PubMed
Key Laboratory of Sports Technique, Tactics and Physical Function of General Administration of Sport of China, Scientific Research Center, Guangzhou Sport University, Guangzhou, China
Search for other papers by Liangming Li in
Google Scholar
PubMed
.1210/en.2012-1193 22778214 22 Zhao Y Meng C Wang Y Huang H Liu W Zhang JF Zhao H Feng B Leung PS Xia Y . IL-1beta inhibits beta-klotho expression and FGF19 signaling in hepatocytes . American Journal of Physiology: Endocrinology and Metabolism 2016
Search for other papers by Linfei Yang in
Google Scholar
PubMed
Search for other papers by Xiao Yu in
Google Scholar
PubMed
European Pancreas Center, Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany
Search for other papers by Yongchao Yang in
Google Scholar
PubMed
. Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis. Nature Communications 2017 8 15433 . ( https://doi.org/10.1038/ncomms15433 ) 38 Kishi Y Okudaira S Tanaka M Hama K Shida D Kitayama J Yamori T
Search for other papers by Mohammed S Razzaque in
Google Scholar
PubMed
effects on the musculoskeletal system, the neuronal system, the immune system, and inflammatory pathways ( 1 , 4 , 34 , 62 , 63 , 64 , 65 , 66 ). FGF23 FGF23 is a member of the endocrine FGF family, along with FGF19 and FGF21 ( 9
Search for other papers by Maximilian Bielohuby in
Google Scholar
PubMed
Search for other papers by Martin Bidlingmaier in
Google Scholar
PubMed
Search for other papers by Uwe Schwahn in
Google Scholar
PubMed
Blouet C Chang JK Chua S Jr. Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism . Molecular Metabolism 2014 3 19 – 28 . ( https://doi.org/10.1016/j.molmet.2013.10.002 ) 24567901 10.1016/j
Search for other papers by Jonathan Hazlehurst in
Google Scholar
PubMed
Search for other papers by Bernard Khoo in
Google Scholar
PubMed
Department of Medicine, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark
Search for other papers by Carolina Brito Lobato in
Google Scholar
PubMed
Search for other papers by Ibiyemi Ilesanmi in
Google Scholar
PubMed
Search for other papers by Sally Abbott in
Google Scholar
PubMed
Search for other papers by Tin Chan in
Google Scholar
PubMed
Search for other papers by Sanesh Pillai in
Google Scholar
PubMed
Search for other papers by Kate Maslin in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK
Search for other papers by Sanjay Purkayastha in
Google Scholar
PubMed
Search for other papers by Barbara McGowan in
Google Scholar
PubMed
Search for other papers by Rob Andrews in
Google Scholar
PubMed
Search for other papers by Eveleigh Nicholson in
Google Scholar
PubMed
Search for other papers by Katherine McCullough in
Google Scholar
PubMed
Search for other papers by Lorraine Albon in
Google Scholar
PubMed
Search for other papers by Rachel Batterham in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Shareen Forbes in
Google Scholar
PubMed
Search for other papers by Gavin Bewick in
Google Scholar
PubMed
Search for other papers by Tricia M-M Tan in
Google Scholar
PubMed
( 10 , 11 , 12 , 13 ), alterations in bile acid kinetics ( 14 ) which may in turn trigger excess FGF-19 secretion ( 15 ), and inflammatory cytokines such as IL-1beta ( 16 ). PBH is also known as ‘late dumping syndrome’. This phenomenon was first